cohbar (otcqx: cwbr and tsxv: cob.u) is the leader in the research and development of mitochondria-based therapeutics (mbts), an emerging class of drugs for the treatment of diseases associated with aging. mbts originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. this groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. mbts offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.
Company profile
Ticker
CWBR
Exchange
Website
CEO
Steven B. Engle
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Cohbar, Inc.
SEC CIK
CWBR stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
27 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
Termination of a Material Definitive Agreement
1 Nov 23
425
Business combination disclosure
25 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
25 Oct 23
425
Business combination disclosure
6 Oct 23
8-K/A
Submission of Matters to a Vote of Security Holders
6 Oct 23
425
Business combination disclosure
4 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
4 Oct 23
Transcripts
CWBR
Earnings call transcript
2022 Q3
11 Nov 22
CWBR
Earnings call transcript
2022 Q2
16 Aug 22
CWBR
Earnings call transcript
2022 Q1
17 May 22
CWBR
Earnings call transcript
2021 Q4
30 Mar 22
CWBR
Earnings call transcript
2021 Q3
16 Nov 21
CWBR
Earnings call transcript
2021 Q2
11 Aug 21
CWBR
Earnings call transcript
2021 Q1
18 May 21
CWBR
Earnings call transcript
2020 Q4
31 Mar 21
CWBR
Earnings call transcript
2020 Q3
17 Nov 20
CWBR
Earnings call transcript
2020 Q2
13 Aug 20
Latest ownership filings
SC 13G/A
Cohen Pinchas
8 Feb 23
SC 13G/A
Barzilai Nir Yacov
8 Feb 23
4
Jeffrey Francis Biunno
3 Aug 22
4
Joseph J. Sarret
3 Aug 22
4
Stephanie Tozzo
12 Jul 22
3
Stephanie Tozzo
12 Jul 22
SC 13G/A
CVI Investments, Inc.
14 Feb 22
SC 13G/A
Cohen Pinchas
1 Feb 22
SC 13G/A
Barzilai Nir Yacov
1 Feb 22
4
Jeffrey Francis Biunno
3 Jan 22
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.19 mm | 6.19 mm | 6.19 mm | 6.19 mm | 6.19 mm | 6.19 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.48 mm | 1.09 mm | 601.02 k | 661.69 k |
Cash used (since last report) | n/a | n/a | 14.47 mm | 10.71 mm | 5.89 mm | 6.48 mm |
Cash remaining | n/a | n/a | -8.28 mm | -4.52 mm | 306.77 k | -287.35 k |
Runway (months of cash) | n/a | n/a | -5.6 | -4.1 | 0.5 | -0.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 1 |
Closed positions | 2 |
Increased positions | 3 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 152.33 mm |
Total shares | 4.59 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 4.52 mm | $0.00 |
Vanguard | 17.67 k | $49.29 mm |
Geode Capital Management | 15.14 k | $43.01 mm |
Renaissance Technologies | 13.36 k | $37.00 k |
Two Sigma Investments | 13.17 k | $36.75 mm |
Advisor | 2.46 k | $6.86 mm |
BLK Blackrock | 2.10 k | $5.86 mm |
Tower Research Capital | 1.96 k | $5.46 mm |
MS Morgan Stanley | 1.27 k | $3.55 mm |
USB U.S. Bancorp. | 263.00 | $734.00 k |